{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:59:24Z","timestamp":1793350764461,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["LJ232410163022"],"award-info":[{"award-number":["LJ232410163022"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172086"],"award-info":[{"award-number":["82172086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFE0201700"],"award-info":[{"award-number":["2020YFE0201700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mtbio.2025.102535","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T06:02:37Z","timestamp":1762581757000},"page":"102535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Harnessing macrophages for precision drug delivery and cancer therapy: Strategies, advances and challenges"],"prefix":"10.1016","volume":"35","author":[{"given":"Muse","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxin","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0978-2363","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.mtbio.2025.102535_bib1","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem. Rev."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102535_bib2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41587-022-01462-4","volume":"40","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102535_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib4","article-title":"Overview of perspectives on cancer, newer therapies, and future directions","volume":"10","author":"Joshi","year":"2024","journal-title":"Oncology and Translational Medicine"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102535_bib5","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1021\/acsnano.9b03924","article-title":"Role of nanoparticle mechanical properties in cancer drug delivery","volume":"13","author":"Hui","year":"2019","journal-title":"ACS Nano"},{"issue":"17","key":"10.1016\/j.mtbio.2025.102535_bib6","first-page":"1825","article-title":"Nanoparticle strategy enhances delivery of cancer drugs","volume":"315","author":"Hampton","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.mtbio.2025.102535_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-040210-162544","article-title":"Nanoparticle delivery of cancer drugs","volume":"63","author":"Wang","year":"2012","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102535_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd.2016.60","article-title":"Nanoparticles improve profile of molecularly targeted cancer drug","volume":"15","author":"Cully","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"21","key":"10.1016\/j.mtbio.2025.102535_bib9","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1039\/C9CS00309F","article-title":"Nanoparticles' interactions with vasculature in diseases","volume":"48","author":"Tee","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2025.102535_bib10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"Acharya","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2025.102535_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.11.021","article-title":"An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products doxil\u00ae, caelyx\u00ae, DOXOrubicin, and SinaDoxosome","volume":"221","author":"Wibroe","year":"2016","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7150\/jca.22163","article-title":"Recombinant nanocomposites by the clinical drugs of abraxane\u00ae and herceptin\u00ae as sequentially dual-targeting therapeutics for breast cancer","volume":"9","author":"Ding","year":"2018","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.mtbio.2025.102535_bib14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.mtbio.2025.102535_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102535_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41565-023-01323-4","article-title":"Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures","volume":"18","author":"Zhu","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.apsb.2017.12.001","article-title":"Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy","volume":"8","author":"Huang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102535_bib18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/acscentsci.6b00190","article-title":"Does nanomedicine have a delivery problem?","volume":"2","author":"Torrice","year":"2016","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-025-02368-w","article-title":"Nanomedicine in cancer therapeutics: current perspectives from bench to bedside","volume":"24","author":"Abdullah","year":"2025","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.mtbio.2025.102535_bib20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","article-title":"The dose threshold for nanoparticle tumour delivery","volume":"19","author":"Ouyang","year":"2020","journal-title":"Nat. Mater."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","article-title":"Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting","volume":"145","author":"Li","year":"2010","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/14686996.2019.1590126","article-title":"Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review","volume":"20","author":"Shiraishi","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.102535_bib23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2017.12.015","article-title":"Crossing the blood-brain barrier with nanoparticles","volume":"270","author":"Zhou","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2025.102535_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114840","article-title":"Engineering cells for precision drug delivery: new advances, clinical translation, and emerging strategies","volume":"197","author":"Chao","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"17","key":"10.1016\/j.mtbio.2025.102535_bib25","article-title":"Living leukocyte-based drug delivery systems","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.102535_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121202","article-title":"Clinical progress and advanced research of red blood cells based drug delivery system","volume":"279","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102535_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114394","article-title":"Cell-based drug delivery systems and their in vivo fate","volume":"187","author":"Yang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"13","key":"10.1016\/j.mtbio.2025.102535_bib28","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.7150\/thno.99257","article-title":"Theoretical basis, state and challenges of living cell-based drug delivery systems","volume":"14","author":"Liu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2025.102535_bib29","first-page":"150","article-title":"Convergence of nanomedicine and neutrophils for drug delivery","volume":"35","author":"Yuan","year":"2024","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib30","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1186\/s12951-025-03658-7","article-title":"Outer membrane vesicles-based nano-regulator for cancer immunotherapy by modulating neutrophils N1 polarization and hitchhiking delivery","volume":"23","author":"Liu","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2025.102535_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1650760","article-title":"Targeting immune cell migration as therapy for inflammatory disease: a review","volume":"16","author":"Song","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.102535_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2025.103296","article-title":"Engineered T cells and macrophages: two arms to seize solid tumors","volume":"93","author":"Russo","year":"2025","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.mtbio.2025.102535_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.addr.2017.05.010","article-title":"Macrophage-based therapeutic strategies in regenerative medicine","volume":"122","author":"Spiller","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7446","key":"10.1016\/j.mtbio.2025.102535_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2025.102535_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114136","article-title":"Leveraging macrophages for cancer theranostics","volume":"183","author":"Liu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2025.102535_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1589553","article-title":"Optimizing monocyte-derived immune cell cultures: comparing xeno-free and xenogeneic conditions","volume":"16","author":"Marek","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/imr.12223","article-title":"Macrophage heterogeneity in tissues: phenotypic diversity and functions","volume":"262","author":"Gordon","year":"2014","journal-title":"Immunol. Rev."},{"issue":"40","key":"10.1016\/j.mtbio.2025.102535_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.102535_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176006","article-title":"Artificially induced in situ macrophage polarization: an emerging cellular therapy for immuno-inflammatory diseases","volume":"957","author":"Chaterjee","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102535_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/ot9.0000000000000063","article-title":"Remodeling tumor-associated macrophages in the tumor microenvironment","volume":"10","author":"Chen","year":"2024","journal-title":"Oncology and Translational Medicine"},{"key":"10.1016\/j.mtbio.2025.102535_bib41","first-page":"55","article-title":"Macrophage based drug delivery: key challenges and strategies","volume":"38","author":"Guo","year":"2024","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental Guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102535_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41568-021-00393-7","article-title":"Home advantage for tissue-resident macrophages","volume":"21","author":"Harjes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102535_bib44","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","article-title":"Functional macrophage cell lines transformed by abelson leukemia virus","volume":"15","author":"Raschke","year":"1978","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.mtbio.2025.102535_bib46","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.7150\/thno.60427","article-title":"Macrophage-mediated tumor homing of hyaluronic acid nanogels loaded with polypyrrole and anticancer drug for targeted combinational photothermo-chemotherapy","volume":"11","author":"Xiao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2025.102535_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2015.01.039","article-title":"Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer","volume":"204","author":"Fu","year":"2015","journal-title":"J. Contr. Release"},{"issue":"22","key":"10.1016\/j.mtbio.2025.102535_bib48","doi-asserted-by":"crossref","first-page":"14441","DOI":"10.1021\/acsnano.4c01120","article-title":"Pluronic-Based nanoparticles for delivery of Doxorubicin to the tumor microenvironment by binding to macrophages","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"issue":"21","key":"10.1016\/j.mtbio.2025.102535_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw7191","article-title":"Macrophage hitchhiking nanomedicine for enhanced \u03b2-elemene delivery and tumor therapy","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102535_bib50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00280-018-3735-0","article-title":"Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?","volume":"83","author":"Zheng","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.mtbio.2025.102535_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1679919","article-title":"Anti-inflammatory and antioxidant effects of Pogostemon stellatus (Lour.) Kuntze via MAPK, NF-\u03baB, and Nrf2 signaling pathways in LPS-activated RAW 264.7 macrophages","volume":"16","author":"Yoon","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102535_bib52","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1021\/acs.jproteome.5c00416","article-title":"A phosphoproteomic analysis of mycobacterial PknG-Mediated host immune evasion","volume":"24","author":"Baros-Steyl","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mtbio.2025.102535_bib53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2016.07.018","article-title":"Macrophage-based cell therapies: the long and winding road","volume":"240","author":"Lee","year":"2016","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102535_bib54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jlb.64.4.419","article-title":"Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives","volume":"64","author":"Andreesen","year":"1998","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2018-213112","article-title":"M-CSF and GM-CSF monocyte-derived macrophages in systemic sclerosis: the two sides of the same coin?","volume":"78","author":"Lescoat","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"26","key":"10.1016\/j.mtbio.2025.102535_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201701093","article-title":"Ly6Chi monocytes delivering pH-Sensitive micelle loading Paclitaxel improve targeting therapy of metastatic breast cancer","volume":"27","author":"Lang","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102535_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nnano.2014.62","article-title":"Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery","volume":"9","author":"Smith","year":"2014","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102535_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2217\/nnm-2017-0266","article-title":"Monocyte-mediated chemotherapy drug delivery in glioblastoma","volume":"13","author":"Wang","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.mtbio.2025.102535_bib59","article-title":"Bone marrow-derived macrophage production","volume":"81","author":"Trouplin","year":"2013","journal-title":"JoVE J."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102535_bib60","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/cns.13964","article-title":"The therapeutic potential of bone marrow-derived macrophages in neurological diseases","volume":"28","author":"Zhou","year":"2022","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102535_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.201900162","article-title":"Macrophage-Mediated delivery of hypoxia-activated prodrug nanoparticles","volume":"3","author":"Evans","year":"2020","journal-title":"Adv. Therapeut."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and functions of tissue macrophages","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.mtbio.2025.102535_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.617879","article-title":"Tissue-Resident macrophage development and function","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102535_bib64","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1021\/acsnano.1c00114","article-title":"Primary macrophage-based microrobots: an effective tumor therapy in vivo by dual-targeting function and near-infrared-triggered drug release","volume":"15","author":"Nguyen","year":"2021","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.mtbio.2025.102535_bib65","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/acs.nanolett.3c00354","article-title":"Alveolar macrophages-mediated translocation of intratracheally delivered perfluorocarbon nanoparticles to achieve lung cancer 19F-MR imaging","volume":"23","author":"Wang","year":"2023","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib66","first-page":"14.20.1","article-title":"Measurement of macrophage growth and differentiation","volume":"92","author":"Chitu","year":"2011","journal-title":"Curr. Protoc. Im."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102535_bib67","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/08820139.2024.2382805","article-title":"A comprehensive protocol for the collection, differentiation, cryopreservation, and resuscitation of primary murine Bone Marrow Derived Macrophages (BMDM)","volume":"53","author":"Luu","year":"2024","journal-title":"Immunol. Investig."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101204","article-title":"Large-scale generation of IL-12 secreting macrophages from human pluripotent stem cells for cancer therapy","volume":"32","author":"Kang","year":"2024","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.mtbio.2025.102535_bib69","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jconrel.2021.11.028","article-title":"Nanomaterials targeting tumor associated macrophages for cancer immunotherapy","volume":"341","author":"Zhao","year":"2022","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s40820-024-01455-9","article-title":"Nanomaterial-Based repurposing of macrophage metabolism and its applications","volume":"16","author":"Meng","year":"2024","journal-title":"Nano-Micro Lett."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102535_bib71","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41577-024-01081-x","article-title":"Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease","volume":"25","author":"Tiwari","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib72","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/exd.14729","article-title":"Future prospects for cancer immunotherapy using induced pluripotent stem cell-derived dendritic cells or macrophages","volume":"32","author":"Fukushima","year":"2023","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib73","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/10717544.2020.1831103","article-title":"Cell-mediated targeting drugs delivery systems","volume":"27","author":"Yu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mtbio.2025.102535_bib74","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biomaterials.2017.06.017","article-title":"Macrophages with cellular backpacks for targeted drug delivery to the brain","volume":"140","author":"Klyachko","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2025.102535_bib75","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.2147\/IJN.S110146","article-title":"Nanomedicine engulfed by macrophages for targeted tumor therapy","volume":"11","author":"Li","year":"2016","journal-title":"Int J Nanomedicine"},{"issue":"13","key":"10.1016\/j.mtbio.2025.102535_bib76","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.biomaterials.2010.01.065","article-title":"Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib77","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.taap.2008.06.009","article-title":"The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line","volume":"232","author":"Clift","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102535_bib78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0248-4900(98)80338-9","article-title":"Analysis of rates of receptor-mediated endocytosis and exocytosis of a fluorescent hapten-protein conjugate in murine macrophage: implications for antigen processing","volume":"90","author":"Weaver","year":"1998","journal-title":"Biol. Cell"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102535_bib79","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/acs.chemrestox.9b00467","article-title":"Safe-by-Design of Glucan nanoparticles: size matters when assessing the immunotoxicity","volume":"33","author":"Cola\u00e7O","year":"2020","journal-title":"Chem. Res. Toxicol."},{"issue":"29","key":"10.1016\/j.mtbio.2025.102535_bib80","doi-asserted-by":"crossref","first-page":"11901","DOI":"10.1073\/pnas.0705326104","article-title":"Making polymeric micro- and nanoparticles of complex shapes","volume":"104","author":"Champion","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"37","key":"10.1016\/j.mtbio.2025.102535_bib81","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1002\/smll.201601282","article-title":"Macrophages as active nanocarriers for targeted early and adjuvant cancer chemotherapy","volume":"12","author":"Si","year":"2016","journal-title":"Small"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib82","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jconrel.2010.07.116","article-title":"Polymer particle shape independently influences binding and internalization by macrophages","volume":"147","author":"Sharma","year":"2010","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102535_bib83","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owens","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"13","key":"10.1016\/j.mtbio.2025.102535_bib85","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.biomaterials.2011.01.021","article-title":"The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles","volume":"32","author":"Xiao","year":"2011","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102535_bib86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tips.2022.01.009","article-title":"The consequences of particle uptake on immune cells","volume":"43","author":"Sharma","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102535_bib87","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.mtbio.2025.102535_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114032","article-title":"Cellular transformers for targeted therapy","volume":"179","author":"Chen","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2025.102535_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120670","article-title":"In situ poly I:C released from living cell drug nanocarriers for macrophage-mediated antitumor immunotherapy","volume":"269","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"issue":"37","key":"10.1016\/j.mtbio.2025.102535_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202102440","article-title":"Supramolecular macrophage-liposome marriage for cell-hitchhiking delivery and immunotherapy of Acute pneumonia and melanoma","volume":"31","author":"Gao","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102535_bib91","article-title":"Cell-Based drug delivery and use of nano-and microcarriers for cell functionalization","volume":"7","author":"Timin","year":"2018","journal-title":"Adv. Healthcare Mater."},{"issue":"19","key":"10.1016\/j.mtbio.2025.102535_bib92","article-title":"Metal-Coordinated adsorption of nanoparticles to macrophages for targeted cancer therapy","volume":"33","author":"Zhu","year":"2023","journal-title":"Adv. Funct. Mater."},{"issue":"6","key":"10.1016\/j.mtbio.2025.102535_bib93","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1021\/acsnano.2c03573","article-title":"Live macrophage-delivered doxorubicin-loaded liposomes effectively treat triple-negative breast cancer","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2025.102535_bib94","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jconrel.2024.02.003","article-title":"Genetically engineered macrophages as living cell drug carriers for targeted cancer therapy","volume":"367","author":"Ning","year":"2024","journal-title":"J. Contr. Release"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102535_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202305384","article-title":"Bacteria-Based backpacks to enhance adoptive macrophage transfer against solid tumors","volume":"36","author":"An","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib96","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13045-020-00983-2","article-title":"Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib97","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mtbio.2025.102535_bib98","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jconrel.2024.11.064","article-title":"An engineered \u03b11\u03b21 integrin-mediated Fc\u03b3RI signaling component to control enhanced CAR macrophage activation and phagocytosis","volume":"377","author":"DU","year":"2025","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2025.102535_bib99","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102535_bib100","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mtbio.2025.102535_bib101","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1021\/nl072209h","article-title":"A cellular trojan horse for delivery of therapeutic nanoparticles into tumors","volume":"7","author":"Choi","year":"2007","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102535_bib102","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1158\/0008-5472.CAN-12-3056","article-title":"Macrophage delivery of an oncolytic virus abolishes tumor regrowth and metastasis after chemotherapy or irradiation","volume":"73","author":"Muthana","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.mtbio.2025.102535_bib103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2020.08.052","article-title":"Tumor targeted combination therapy mediated by functional macrophages under fluorescence imaging guidance","volume":"328","author":"Zhang","year":"2020","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib104","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1080\/10717544.2018.1502839","article-title":"Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy","volume":"25","author":"Pang","year":"2018","journal-title":"Drug Deliv."},{"issue":"48","key":"10.1016\/j.mtbio.2025.102535_bib105","doi-asserted-by":"crossref","first-page":"56825","DOI":"10.1021\/acsami.1c12406","article-title":"Macrophage-Mediated porous magnetic nanoparticles for multimodal imaging and postoperative photothermal therapy of gliomas","volume":"13","author":"Wang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"16","key":"10.1016\/j.mtbio.2025.102535_bib106","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.biomaterials.2012.02.022","article-title":"Use of macrophages to deliver therapeutic and imaging contrast agents to tumors","volume":"33","author":"Choi","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib107","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.1038\/s41467-024-52500-5","article-title":"Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2025.102535_bib108","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biomaterials.2017.04.012","article-title":"Cell-borne 2D nanomaterials for efficient cancer targeting and photothermal therapy","volume":"133","author":"Li","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib109","doi-asserted-by":"crossref","DOI":"10.1097\/ot9.0000000000000067","article-title":"Advancements in conventional cancer therapy combined with immunotherapy","volume":"11","author":"Li","year":"2025","journal-title":"Oncology and Translational Medicine"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41467-020-20723-x","article-title":"Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib111","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s40820-020-00531-0","article-title":"Nanoparticle-Loaded polarized-macrophages for enhanced tumor targeting and cell-chemotherapy","volume":"13","author":"Hou","year":"2020","journal-title":"Nano-Micro Lett."},{"issue":"18","key":"10.1016\/j.mtbio.2025.102535_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202203356","article-title":"Engineered macrophages-based uPA-Scavenger load gemcitabine to prompt robust treating cancer metastasis","volume":"12","author":"Rao","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib113","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-021-24564-0","article-title":"Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102535_bib114","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1021\/acs.nanolett.7b02330","article-title":"Inflammatory monocytes loading protease-sensitive nanoparticles enable lung metastasis targeting and intelligent drug release for anti-metastasis therapy","volume":"17","author":"He","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.mtbio.2025.102535_bib115","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58688","article-title":"Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment","volume":"10","author":"Nicolas-Boluda","year":"2021","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102535_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060785","article-title":"Cytotoxic effects of doxorubicin on cancer cells and macrophages depend differently on the microcarrier structure","volume":"16","author":"Kalenichenko","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2025.102535_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123069","article-title":"Cellular drug delivery system for disease treatment","volume":"641","author":"Wang","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102535_bib118","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41598-019-55909-x","article-title":"Biomimetic cellular vectors for enhancing drug delivery to the lungs","volume":"10","author":"Evangelopoulos","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425011068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425011068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:12:41Z","timestamp":1773328361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425011068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":118,"alternative-id":["S2590006425011068"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102535","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing macrophages for precision drug delivery and cancer therapy: Strategies, advances and challenges","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102535"}}